Company Filing History:
Years Active: 2014-2017
Title: The Innovative Contributions of Timothy L. Frankel
Introduction
Timothy L. Frankel is a notable inventor based in New York, NY (US), recognized for his significant contributions to the field of cancer research. With a focus on T cell receptors, Frankel has developed innovative methods that aim to improve cancer detection and treatment. He holds 2 patents that reflect his dedication to advancing medical science.
Latest Patents
Frankel's latest patents revolve around T cell receptors (TCRs) that exhibit antigenic specificity for cancer antigens, such as tyrosinase. These inventions include related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, and pharmaceutical compositions. Furthermore, his patents provide methods for detecting the presence of cancer in a host and for treating or preventing cancer using the inventive TCRs or related materials.
Career Highlights
Timothy L. Frankel is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to public health and innovative research.
Collaborations
Frankel has collaborated with esteemed colleagues in the field, including Steven A. Rosenberg and Richard A. Morgan. These partnerships enhance the impact of his research and contribute to the advancement of cancer therapies.
Conclusion
Timothy L. Frankel's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents and collaborations reflect a commitment to improving patient outcomes through scientific discovery.